Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma: Association with angiogenesis and tumor progression

Cancer

Volumn 79, Issue 2, 1997, Pages 206-213

  Inoue, Kimitoshi ^a   Ozeki, Yuichi ^a   Suganuma, Toshiyuki ^a   Sugiura, Yoshiaki ^a   Tanaka, Susumu ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

angiogenesis; esophageal carcinoma; microvessel density; vascular endothelial growth factor (VEGF)

Indexed keywords

BLOOD CLOTTING FACTOR 8 ANTIBODY; MESSENGER RNA; POLYCLONAL ANTIBODY; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER INVASION; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031024216     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970115)79:2<206::AID-CNCR2>3.0.CO;2-I     Document Type: Article

References (27)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent. J Natl Cancer Inst 1990;82:4-6.
2. Bouck N. Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. Cancer Cells 1990;2:179-85.
3. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61.
4. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
5. Russel DS, Rubinstein LJ. Glioblastoma multiforme In: Russel DS, Rubinstein LJ, editors. Pathology of tumors of the nervous system. 5th edition. London: Edward Arnold, 1989:219-32.
6. Weinstat-Saslow D, Steeg PS. Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J 1994;8:401-7.
7. Klagsbrun M. Angiogenesis. In: Sporn MB, Roberts AB, editors. Handbook of experimental pharmacology. Volume 95/ 2. Berlin: Springer-Verlag, 1990:549-86.
8. Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990;1032:89-118.
9. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 1989;86:7311-5.
10. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-8.
11. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.
12. Japanese Society for Esophageal Diseases. Guidelines for the clinical and pathologic studies on carcinoma of the esophagus. 8th edition. Tokyo: Kanehara & Co. Ltd., 1992.
13. Ferrara N, Winer J, Burton T. Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors 1991;5:141-8.
14. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Sawada T, Yamashita Y, et al. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 1995;13:477-81.
15. Yamazaki K, Abe S, Takekawa H, Sukoh N, Watanabe H, Ogura S, et al. Tumor angiogenesis in human lung adenocarcinoma. Cancer 1994;74:2245-50.
16. Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989-91.
17. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses rumor growth in vivo. Science 1993;362:841-4.
18. Kondo S, Asano M, Suzuki H. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem Biophys Res Commun 1993;194:1234-41.
19. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992;13:18-32.
20. Dvorak HF, Sioussat TM, Brown LF, Berse B, Sotrel NA, Manseau EJ, et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 1991;174:1275-8.
21. Akiyama H, Tsurumaru M, Kawamura O, Ono Y. Principle of surgical treatment for carcinoma of the esophagus. Ann Surg 1981;194:438-46.
22. Patil P, Redkar A, Patel G, Mistry RC, Deshpande RK, Mittra I, et al. Prognosis of operable squamous cell carcinoma of the esophagus. Cancer 1993;72:20-4.
23. Skiner DB. En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg 1983;85:59-71.
24. Lu YK, Li YM, Gu YZ. Cancer of esophagus and esophagogastric junction: analysis of results of 1,025 resections after 5 to 20 years. Ann Thorac Surg 1987;43:176-81.
25. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Mosesm M, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma. Cell 1994;79:315-28.
26. Yamaoka M, Yamamoto T, Masaki T. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor o-(chloroacetyl-carbamoyl) fumagiliol (TNP-470; AGM-1470). Cancer Res 1993;53:4262-7.
27. Yanase T, Tamura M, Fujita K. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res 1993; 53:2566-70.